What is the recommended treatment for tinea capitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Tinea Capitis

The first-line treatment for tinea capitis should be oral antifungal therapy with the choice guided by the causative organism: terbinafine for Trichophyton species infections and griseofulvin for Microsporum species infections. 1, 2

Diagnostic Approach

  • Obtain scalp samples via scalpel scraping, hair pluck, brush, or swab
  • Process all specimens for microscopy and culture
  • Treatment can be initiated while awaiting confirmatory mycology if clinical signs are present (scale, lymphadenopathy, alopecia, or kerion) 1

First-Line Treatment Options

For Trichophyton species (T. tonsurans, T. violaceum, T. soudanense):

  • Terbinafine (oral) for 2-4 weeks 1, 2
    • Dosing by weight:
      • < 20 kg: 62.5 mg daily
      • 20-40 kg: 125 mg daily
      • 40 kg: 250 mg daily

For Microsporum species (M. canis, M. audouinii):

  • Griseofulvin (oral) for 6-8 weeks 1, 2, 3
    • Dosing by weight:
      • < 50 kg: 15-20 mg/kg/day (single or divided doses)
      • 50 kg: 1 g/day (single or divided doses)

Adjunctive Therapy

  • Ketoconazole 2% shampoo or selenium sulfide shampoo to reduce spore transmission 2, 4
  • Apply 2-3 times weekly during treatment

Second-Line Treatment

  • Itraconazole: 5 mg/kg/day for 4 weeks 1, 2
    • Effective against both Trichophyton and Microsporum species
    • Consider when first-line treatment fails

Treatment Considerations

  • Duration: Continue treatment until mycological cure is achieved 2, 3
  • Follow-up: Clinical improvement expected within 1-2 weeks; mycological cure is the definitive endpoint 2
  • Treatment failure: Consider compliance issues, suboptimal absorption, organism insensitivity, or reinfection 1

Important Clinical Pearls

  1. Topical therapy alone is not effective for tinea capitis; oral therapy is required 1, 2, 4
  2. Medication choice should be guided by the causative organism when possible 1, 2
  3. Prevention of reinfection:
    • Screen and treat family members for anthropophilic infections
    • Avoid sharing personal items (combs, brushes, hats)
    • Clean shared items with disinfectant 2

Special Considerations

  • Terbinafine is less effective against Microsporum species and may require higher doses or longer treatment periods for Trichophyton infections 1
  • Griseofulvin is generally well-tolerated with extensive safety data in children; side effects include gastrointestinal disturbances and rashes in <8% of patients 1, 2
  • Terbinafine is generally well-tolerated but can cause gastrointestinal and dermatological side effects; rare serious reactions include Stevens-Johnson syndrome and hepatic toxicity 2

Treatment Algorithm

  1. Identify causative organism through mycology when possible
  2. Select oral antifungal based on organism:
    • Trichophyton → Terbinafine
    • Microsporum → Griseofulvin
  3. Add adjunctive antifungal shampoo
  4. Continue treatment until mycological cure
  5. If treatment fails after 4-8 weeks, switch to second-line therapy (itraconazole)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fungal Infections Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Successful treatment of tinea capitis with 2% ketoconazole shampoo.

International journal of dermatology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.